KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,666,721 | -1.2% | 276,918 | -7.6% | 0.00% | 0.0% |
Q2 2023 | $2,698,272 | +24.0% | 299,808 | +8.3% | 0.00% | 0.0% |
Q1 2023 | $2,176,481 | +16.2% | 276,906 | -0.1% | 0.00% | +100.0% |
Q4 2022 | $1,872,999 | +18630.0% | 277,071 | +41315.7% | 0.00% | – |
Q3 2022 | $10,000 | -52.4% | 669 | -68.8% | 0.00% | – |
Q2 2022 | $21,000 | -83.1% | 2,147 | -74.6% | 0.00% | – |
Q1 2022 | $124,000 | -82.7% | 8,437 | -84.4% | 0.00% | – |
Q4 2021 | $716,000 | +41.5% | 54,127 | +86.7% | 0.00% | – |
Q3 2021 | $506,000 | -78.4% | 28,988 | -70.4% | 0.00% | -100.0% |
Q2 2021 | $2,344,000 | +269.7% | 97,817 | +296.3% | 0.00% | – |
Q1 2021 | $634,000 | +832.4% | 24,685 | +590.3% | 0.00% | – |
Q4 2020 | $68,000 | +466.7% | 3,576 | +289.5% | 0.00% | – |
Q3 2020 | $12,000 | -57.1% | 918 | -59.7% | 0.00% | – |
Q2 2020 | $28,000 | -6.7% | 2,280 | -41.3% | 0.00% | – |
Q1 2020 | $30,000 | -33.3% | 3,887 | +53.6% | 0.00% | – |
Q4 2019 | $45,000 | +650.0% | 2,530 | +337.0% | 0.00% | – |
Q3 2019 | $6,000 | -91.7% | 579 | -82.2% | 0.00% | – |
Q2 2019 | $72,000 | -79.4% | 3,260 | -73.4% | 0.00% | – |
Q1 2019 | $350,000 | – | 12,238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |